Catalyst Pharmaceutical CPRX Accrued Milestone Payment Classified As License And Acquired Intangibles Net
Accrued Milestone Payment Classified As License And Acquired Intangibles Net at other companies
Other financials
Where this comes from
Reported directly by Catalyst Pharmaceutical in its filing.
Tagged under the XBRL concept cprx:AccruedMilestonePaymentClassifiedAsLicenseAndAcquiredIntangiblesNet.
The official record: Catalyst Pharmaceutical’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's accrued milestone payment classified as license and acquired intangibles net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Catalyst Pharmaceutical's accrued milestone payment classified as license and acquired intangibles net?
- Catalyst Pharmaceutical (CPRX) reported accrued milestone payment classified as license and acquired intangibles net of $3.13M in Q4 2025.
- What does accrued milestone payment classified as license and acquired intangibles net mean?
- This metric represents the non-cash accrual of contractual milestone obligations related to the acquisition of intellectual property, licenses, or intangible assets. It reflects future payment commitments triggered by the achievement of specific clinical, regulatory, or commercial development goals. Monitoring this figure helps investors understand the company's long-term capital commitments and the financial impact of its business development and pipeline expansion strategy.